Trade Agreement: NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy:
Comprehensive Land Claim Agreement: No
Nature of Requirements:
Automated IHC/IF/ISH Staining Syste
31184-16877A/A
NRC’s Human Health Therapeutic (HHT) portfolio has a requirement for a benchtop, fully automated immunohistochemical (IHC), immunofluorescence (IF), in situ hybridization (ISH) staining instrument. HHT’s mandate is to offer IHC/IF/ISH services to industrial and internal clients. These clients perform drug development research and by offering this service, HHT facilitates the progress of the drug research. HHT is a fee for service portfolio and relies on client staining service demands as its sole revenue base. The staining instrument is required to address the exponential and sudden increase in client demands for IHC/IF/ISH services. Inability to address the increased workload will result in clients directing their requirements to other sources. The automated staining instrument will permit on-board slide baking, de-waxing, and performance of all pre-treatment steps, primary antibody application and detection, including hematoxylin counterstaining. In addition to ensuring quality control and quality assurance, the new staining instrument will provide consistent staining data results vis-à-vis the current manual system.
Complete detailed specifications are identified in the Request for Proposal document.
Delivery is requested by March 17, 2017 to Ottawa, Ontario.
Gauthier, Martin
Telephone No. - (613) 404-8642
Fax No. - (819) 956-3814
Delivery Date: Above-mentioned
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
